medi-5752,cadonilimab
astrazeneca,akesobio
['kidney cancer', 'ak-104', 'nsclc', 'medi5752 ', 'sclc']
2 in 1! keep an eye on pd-1/ctla-4 bispecific antibodies.
. relapsed cervical cancer - ak-104 + chemo : orr=66-92%
. 1st line kidney cancer - medi5752 : orr=58%
it comes with a price: high immune related aes.
medi5752 is currently tested with chemo in 1st line nsclc. #asco22 
Medical Oncologist - Lung cancer & thymic tumors. Head of Clinical Research @GustaveRoussy - Head of Scientific Chairs Council @EORTC. Tweets are my own.